Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase-dependent pathway

Journal of Clinical Investigation

Volumn 102, Issue 1, 1998, Pages 165-175

  Capodici, Constance ^a   Pillinger, Michael H ^a,b,c   Han, Gene ^a   Philips, Mark R ^a   Weissmann, Gerald ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5 Lipoxygenase; Adhesion; Arachidonic acid; Erk; Neutrophils

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; INTEGRIN; RAF PROTEIN;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MOLECULAR DYNAMICS; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0032128337     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI592     Document Type: Article

References (72)

1. Cronstein, B.N., and G. Weissmann. 1995. Targets for antiinflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 35:449-462.
2. Morel, F., J. Doussiere, and P.V. Vignais. 1991. The superoxide-generating oxidase of phagocytic cells: physiological, molecular and pathological aspects. Eur. J. Biochem. 201:523-546.
3. Abramson, S.B., B. Cherksey, D. Gude, J. Leszczynska-Piziak, M.R. Philips, L. Blau, and G. Weissmann. 1990. Nonsteroidal antiinflammatory drugs exert differential effects on neutrophil function and plasma membrane viscosity: studies in human neutrophils and liposomes. Inflammation. 14:11-30.
4. Cobb, M.H., J.R. Hepler, M. Cheng, and D. Robbins. 1994. The mitogen-activated protein kinases, ERK1 and ERK2. Sem. Cancer Biol. 5:261-268.
5. Chardin, P., J.H. Camonis, N.W. Gale, L. van Aest, J. Schlessinger, M.H. Wigler, and D. Bar-Sagi. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to Grb2. Science. 260:1338-1343.
6. Wartmann, M., and R.J. Davis. 1994. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J. Biol. Chem. 269:6695-6701.
7. Leevers, S.J., H.F. Paterson, and C.J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 369:411-414.
8. Stokoe, D., S.G. MacDonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of raf as a result of recruitment to the plasma membrane. Science. 264:1463-1467.
9. Kyriakis, J.M., H. App. X.-F. Zhang, P. Banerjee, D.L. Brautigan, U.R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature. 358: 417-421.
10. Pillinger, M.H., A.S. Feoktistov, C. Capodici, B. Solitar, J. Levy, T.T. Oei, and M.R. Philips. 1996. Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell-cell adhesion. J. Biol. Chem. 271:12049-12056.
11. Grinstein, S., and W. Furuya. 1992. Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils. J. Biol. Chem. 267:18122-18125.
12. Torres, M., F.L. Hall, and K. O'Neill. 1993. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J. Immunol. 150:1563-1578.
13. Worthen, G.S., N. Avdi, A.M. Buhl, N. Suzuki, and G.L. Johnson. 1994. FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase. J. Clin. Invest. 94:815-823.
14. Gardner, A.M., R.R. Vaillancourt, and G.L. Johnson. 1993. Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins. J. Biol. Chem. 268:17896-17901.
15. Thompson, H.L., M. Shiroo, and J. Saklatvala. 1993. The chemotactic factor N-formylmethionyl-leucyl-phenylalanine activates microtubule-associated protein 2 (MAP) kinase and a MAP kinase kinase in polymorphonuclear leukocytes. Biochem. J. 290:483-488.
16. Downey, G.P., J.R. Butler, J. Brumell, N. Borregaard, L. Kjeldsen, A.K. Sue-A-Quan, and S. Grinstein. 1996. Chemotactic peptide-induced activation of MEK-2, the predominant isoform in human neutrophils. Inhibition by wortmannin. J. Biol. Chem. 271:21005-21011.
17. Yu, H., S.J. Suchard, R. Nairn, and R. Jove. 1995. Dissociation of mitogen-activated protein kinase activation from the oxidativc burst in differentiated HL-60 cells and human neutrophils. J. Biol. Chem. 270:15719-15724.
18. 2. J. Lipid Mediators. 6:23-30.
19. Lewis, R.A., and K.F. Austen. 1988. Leukotrienes. In Inflammation. J.I. Gallin, I.M. Goldstein, and R. Snyderman, editors. Raven Press, Ltd., New York. 121-128.
20. Samuelsson, B., S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176.
21. Abramson, S.B., J. Leszczynska-Piziak, and G. Weissmann. 1991. Arachidonic acid as a second messenger: interactions with a GTP-binding protein of human neutrophils. J. Immunol. 147:231-236.
22. Smith, R.J., L.M. Sam, J.M. Justen, K.L Leach, and D.E. Epps. 1987. Human polymorphonuclear neutrophil activation with arachidonic acid. Br. J. Pharmacol. 91:641-649.
23. 2+ dependent protein kinase. Science. 224:622-626.
24. Badwey, J.A., J.T. Curnutte, J.M. Robinson, C.B. Berde, and M.J. Karnovsky. 1984. Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. J. Biol. Chem. 259:7870-7877.
25. McPhail, L.C., D. Qalliotine-Mann, and K.A. Waite. 1995. Cell-free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase. Proc. Natl Acad. Sci. USA. 92:7931-7935.
26. Aharoni, I., and E. Pick. 1990. Activation of the superoxide-generating NADPH oxidase of macrophages by sodium dodecyl sulfate in a soluble cell-free system: evidence for involvement of a G protein. J. Leuk. Biol. 48:107-115.
27. Hii, C.S.T., A. Ferrante, Y.S. Edwards, Z.H. Huang, P.J. Hartfield, D.A. Rathjen, A. Poulos, and A.W. Murray. 1994. Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism. J. Biol. Chem. 270:4201-4204.
28. Rao, G.N., A.S. Baas, W.C. Glasgow, T.E. Eling, M.S. Runge, and R.W. Alexander. 1994. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269:32586-32591.
29. rac2 from cytosol to plasma membrane is neither necessary nor sufficient for neutrophil NADPH oxidase activity. J. Biol. Chem. 270:11514-11521.
30. Omann, G.M., and M.M. Forasik-Lowes. 1991. Graded G-protein un coupling by pertussis toxin treatment of human polymorphonuclear leukocytes. J. Immunol. 146:1303-1308.
31. 1 inhibits chemoattractant-induced mitogen-activated protein kinase activity in human neutrophils. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:311-316.
32. Philips, M.R., J.P. Buyon, R. Winchester, G. Weissmann, and S.B. Abramson. 1988. Up-regulalion of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation. J. Clin. Invest. 82:495-501.
33. Pillinger, M.H., C. Volker, J.B. Stock, G. Weissmann, and M.R. Philips. 1994. Characterization of a plasma membrane-associated prenylcysteine-directed carboxyl methyltransferase in human neutrophils. J. Biol. Chem. 269: 1486-1442.
34. Knall, C., S. Young, J.A. Nick, A.M. Buhl, G.S. Worthen, and G.L. Johnson. 1996. Interleukin-8 regulation of the ras/raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271:2832-2838.
35. Erickson, A.K., D.M. Payne, P.A. Martino, A.J. Rossomando, J. Shabanowitz, M.J. Weber, D.F. Hunt, and T.W. Sturgill. 1990. Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase. J. Biol. Chem. 265: 19728-19735.
36. z. J. Biol. Chem. 271:2949-2954.
37. Sermon, B.A., J.F. Eccleston, R.H. Skinner, and P.N. Lowe. 1996. Mechanism of inhibition by arachidonic acid of the catalytic activity of Ras GTPase-aclivating proteins. J. Biiol. Chem. 271:1566-1572.
38. Herrmann, F., A. Lindemann, J. Gauss, and R. Mertelsmann. 1990. Cytokine-stimulation of prostaglandin synthesis from endogenous and exogenous arachidonic acids in polymorphonuclear leukocytes involving activation and new synthesis of cyclooxygenase. Eur. J. Immunol. 20:2513-2516.
39. Higgs, G.A., E. McCall, and L.J.F. Youlten. 1975. A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis. Br. J. Pharmacol. 53:539-546.
40. Meade, E.A., W.L. Smith, and D.L. DeWitt. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J. Biol. Chem. 268:6610-6614.
41. 2 of rabbit polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA. 75:2955-2958.
42. Carter, G.W., P.R. Young, D.H. Albert, J. Bouska, R. Dyer, R.L. Bell, J.B. Summers, and D.W. Brooks. 1991. 5-Lipoxygenase inhibitory activity of zileuton. J. Pharmacol. Exp. Ther. 256:929-937.
43. Ondrey, F., J.E. Harris, and K.M. Anderson. 1989. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic metabolism and its partial reversal by leukotriene C4. Cancer Res. 49:1138-1142.
44. Bell, R.L., J.B. Bouska, P.E. Malo, C. Lanni, R.R. Harris, E.R. Otis, A.O. Stewart, D.W. Brooks, and G.W. Carter. 1995. Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors. J. Pharmacol. Exp. Ther. 272:724-731.
45. Yu, S.S., S.W. Djuric, J.H. Dygos, B.S. Tsai, S.K. Paulson, P.F. Smith, and D.J. Fretland. 1994. SC-53228. Drugs Future. 19:1093-1097.
46. Howe, L.R., and C.J. Marshall. 1993. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21 ras and p74 raf-1. J. Biol. Chem. 268:20717-20720.
47. Wu, J., P. Dent, T. Jelinek, A. Wolfman, M.J. Weber, and T.W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 262:1065-1068.
48. Cook, S.J., and F. McCormick. 1993. Inhibition by cAMP of ras-dependent activation of Raf. Science. 262:1069-1072.
49. Erhardt, P., J. Troppmair, U.R. Rapp, and G.M. Cooper. 1995. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol. Cell. Biol. 15:5524-5530.
50. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudly, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
51. Force, T., J.V. Bonventre, G. Heidecker, U. Rapp, and A. Avruch. 1994. Enzymatic characteristics of the c-Raf-1 protein kinase. Proc. Natl. Acad. Sci. USA 91:1270-1274.
52. Morrison, D.K., D.R. Kaplan, J.A. Escobedo, U.R. Rapp, T.M. Roberts, and L.T. Williams. 1989. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF β-receptor. Cell. 58:649-657.
53. Kawauchi, K., A.H. Lazarus, J.S. Sanghera, G.L. Man, and S.L. Pelech. 1996. Regulation of BCR-and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase ac tivities. Mol. Immunol. 33:287-296.
54. Mulcahy, L.S., M.R. Smith, and D.W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature. 313:241-243.
55. Wood, K.W., C. Sarnecki, T.M. Roberts, and J. Blenis. 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: Map kinase, Raf-1, and RSK. Cell. 68:1041-1050.
56. Balch, W.E., and J.E. Rothman. 1985. Characterization of protein transport between successive compartments of the Golgi apparatus: asymmetric properties of donor and acceptor activities in a cell-free system. Arch. Biochem. Biophys. 240:413-425.
57. Bourne, H.R. 1997. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9:134-142.
58. Hunt, T.W., T.A. Fields, P.J. Casey, and E.G. Peralta. 1996. RGS10 is a selective activator of Gai GTPase activity. Nature. 383:175-177.
59. Hamm, H.E., and A. Gilchrist. 1996. Heterotrimeric G proteins. Curr. Opin. Cell Biiol. 8:189-196.
60. Hall, A. 1993. Ras-related proteins. Curr. Opin. Cell Biol. 5:265-268.
61. Grinstein, S., W. Furuya, J.R. Butler, and J. Tseng. 1993. Receptor-mediated activation of multiple serine/threonine kinases in human leukocytes. J. Biol. Chem. 268:20223-20231.
62. Irons, L.I., and A.P. Maclennan. 1979. Isolation of the lymphocytosis promoting factor-haemagglutinin of Burdetella pertussis by affinity chromatography. Biochim. Biophys. Acta. 580:175-185.
63. Boguski, M.S., and F. McCormick. 1993. Proteins regulating Ras and its relatives. Nature. 366:643-654.
64. Maloney, C.G., W.A. Kutchera, K.H. Albertine, T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman. 1998. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J. Immunol. 160:1402-1410.
65. Clancy, R.M., C.A. Dahinden, and T.E. Hugh. 1984. Oxidation of leukotrienes at the omega end: demonstration of a receptor for 20-hydroxy derivatives of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc. Natl. Acad. Sci. USA. 81:5729-5733.
66. 4 to a receptor on human polymorphonuclear leukocytes. J. Exp. Med. 157:628-641.
67. O'Flaherty, J.T., J.R. Surles, J. Redman, D. Jacobson, C. Piantadosi, and R.L. Wykle. 1986. Binding and metabolism of platelet-activating factor by human neutrophils. J. Clin. Invest. 78:381-388.
68. O'Flaherty, J.T., and A.G. Rossi. 1993. 5-Hydroxyecosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J. Biol. Chem. 268:14708-14714.
69. O'Flaherty, J.T., M. Kuroki, A.B. Nixon, J. Wijkander, E. Yee, S.L. Lee, P.K. Smitherman, R.L. Wykle, and L.W. Daniel. 1996. 5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activatcd protein kinase pathway. J. Biol. Chem. 271:17821-17828.
70. O'Flaherty, J.T., D. Jacobson, and J. Redman. 1988. Mechanism involved in the mobilization of neutrophil calcium by 5-hydroxyeicosatetraenoate. J. Immunol. 12:4323-4328.
71. Mocsai, A., B. Bánfi, A. Kapus, G. Farkas, M. Geiszt, L. Buday, A. Faragó, and E. Ligeti. 1997. Differential effects of tyrosine kinase inhibitors and an inhibitor of the mitogen-activated protein kinase cascade and degranulation and superoxide production of human neutrophil granulocytes. Biochem. Pharmacol. 54:781-789.
72. Waddell, T.K., L. Fialkow, C.K. Chan, T.K. Kishimoto, and G.P. Downey. 1995. Signaling functions of L-selectin. J. Biol. Chem. 270:15403-15411.